
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
What is Olaparib?Olaparib is a prescription anticancer drug whose active ingredient is olaparib. It belongs to a class of medications known as PARP inhibitors (poly (ADP-ribose) po···【more】
Article source:Captain MedicineRelease date:2026-04-16Recommended:36
Dosage and Administration of OlaparibOlaparib is available as oral tablets, each containing 150 mg. The standard dosage is 300 mg (two tablets) twice daily, for a total daily dose ···【more】
Article source:Captain MedicineRelease date:2026-04-15Recommended:39
Common Side Effects of Olaparib and Management RecommendationsThe most common side effects of olaparib vary depending on the treatment regimen. When used as monotherapy, common sid···【more】
Article source:Captain MedicineRelease date:2026-04-15Recommended:39
Main Indications of OlaparibFor Ovarian Cancer and Related CancersOlaparib is approved for the treatment of adult patients with advanced ovarian cancer, fallopian tube cancer, or p···【more】
Article source:Captain MedicineRelease date:2026-04-15Recommended:36
What is Olaparib?Olaparib is an oral prescription medication used to treat certain types of cancer. It is a targeted therapy that works by precisely interfering with the survival p···【more】
Article source:Captain MedicineRelease date:2026-04-15Recommended:39
How to take gilteritinib correctly?The recommended dose of gilteritinib is 120 mg once daily, which corresponds to three 40 mg film‑coated tablets. You should take the medication a···【more】
Article source:Captain MedicineRelease date:2026-04-14Recommended:40
Drug Interactions with GilteritinibGilteritinib may affect the metabolism of many other drugs, and vice versa. Therefore, while taking gilteritinib, you must inform your doctor of ···【more】
Article source:Captain MedicineRelease date:2026-04-14Recommended:42
In which situations should gilteritinib absolutely not be taken?You must not use gilteritinib if you are allergic to gilteritinib or any of its other ingredients. Allergic reaction···【more】
Article source:Captain MedicineRelease date:2026-04-14Recommended:39
How does gilteritinib work?In patients with acute myeloid leukemia (AML), the bone marrow produces a large number of abnormal white blood cells. These cells cannot perform normal i···【more】
Article source:Captain MedicineRelease date:2026-04-14Recommended:42
How to Take Gilteritinib CorrectlyGilteritinib can be taken comfortably at home. Follow your healthcare provider's instructions carefully: take one dose at approximately the sa···【more】
Article source:Captain MedicineRelease date:2026-04-10Recommended:40
Common Side Effects and Precautions for GilteritinibIn addition to the serious side effects mentioned above, XOSPATA may also cause a range of more common adverse reactions, includ···【more】
Article source:Captain MedicineRelease date:2026-04-10Recommended:41
What is Gilteritinib?Gilteritinib (generic name: gilteritinib) works in a fundamentally different way from traditional chemotherapy. Traditional chemotherapy fights cancer by killi···【more】
Article source:Captain MedicineRelease date:2026-04-10Recommended:40
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2622025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4832024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2672025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2772025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2582025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:3032025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2652025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2442025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: